Tomoko Fukushige Selected Research

Tomoko Fukushige Research Topics

Disease

8	Neoplasms (Cancer) 01/2022 - 02/2005
7	Fabry Disease (Fabry's Disease) 04/2012 - 01/2004
6	Melanoma (Melanoma, Malignant) 10/2020 - 02/2005
3	Type I Schindler Disease 01/2005 - 10/2002
2	Neoplasm Metastasis (Metastasis) 12/2014 - 10/2012
2	Inborn Genetic Diseases (Disease, Hereditary) 09/2010 - 01/2004
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 07/2019
1	Non-alcoholic Fatty Liver Disease 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Dermatitis 01/2018
1	Inflammation (Inflammations) 01/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Epstein-Barr Virus Infections 02/2017
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 02/2017
1	Necrosis 02/2017
1	Rheumatoid Arthritis 02/2017
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2017
1	Erythropoietic Protoporphyria 03/2014
1	Anemia 03/2014
1	Sideroblastic Anemia 03/2014
1	Hypoxia (Hypoxemia) 03/2013
1	Malnutrition (Nutritional Deficiencies) 03/2013
1	Sandhoff Disease (Sandhoff's Disease) 01/2013
1	Skin Neoplasms (Skin Cancer) 10/2012
1	Heart Diseases (Heart Disease) 04/2012
1	Hypersensitivity (Allergy) 11/2009
1	Mucopolysaccharidosis I (Hurler Syndrome) 09/2008
1	Mucolipidoses (Sialidosis) 03/2007
1	Carcinogenesis 02/2005
1	Pigmented Nevus (Melanocytic Nevus) 02/2005
1	beta-Mannosidosis (beta-Mannosidase Deficiency) 11/2004
1	Neuroaxonal Dystrophies (Neuroaxonal Dystrophy, Late Infantile) 01/2004
1	Nervous System Diseases (Neurological Disorders) 01/2004

Drug/Important Bio-Agent (IBA)

6	EnzymesIBA 04/2012 - 01/2004
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2009
3	LectinsIBA 01/2022 - 03/2007
3	Mannose (D-Mannose)IBA 01/2019 - 01/2006
3	alpha-Galactosidase (Beano)IBA 09/2010 - 01/2006
3	alpha-N-Acetylgalactosaminidase (N-Acetyl-alpha-D-Galactosaminidase)IBA 11/2009 - 01/2004
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2010
2	AsparagineIBA 01/2022 - 10/2020
2	Cadherins (E-Cadherin)IBA 07/2019 - 03/2013
2	Polysaccharides (Glycans)IBA 01/2019 - 02/2012
2	GlycosphingolipidsIBA 01/2013 - 02/2012
2	agalsidase alfaIBA 02/2012 - 01/2006
2	globotriaosylceramide (globotriosylceramide)IBA 09/2010 - 11/2009
2	Monoclonal AntibodiesIBA 03/2007 - 02/2005
2	GlycoconjugatesIBA 03/2007 - 01/2004
1	IntegrinsIBA 01/2022
1	Deoxyglucose (2 Deoxy D glucose)IBA 10/2020
1	AgglutininsIBA 01/2019
1	Detergents (Detergent)IBA 01/2019
1	SolutionsIBA 01/2019
1	Sucrose (Saccharose)IBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	PeroxiredoxinsIBA 01/2019
1	Imiquimod (Aldara)FDA LinkGeneric 01/2018
1	InflammasomesIBA 01/2018
1	CholesterolIBA 01/2018
1	Death-Associated Protein KinasesIBA 02/2017
1	Methotrexate (Mexate)FDA LinkGeneric 02/2017
1	ParaffinIBA 02/2017
1	Biological ProductsIBA 01/2017
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 12/2014
1	Matrix Metalloproteinases (MMPs)IBA 12/2014
1	protoporphyrin IXIBA 03/2014
1	Heme (Haem)IBA 03/2014
1	IronIBA 03/2014
1	Oxygen (Dioxygen)IBA 03/2013
1	Hexosaminidases (Hexosaminidase)IBA 01/2013
1	RNA (Ribonucleic Acid)IBA 10/2012
1	GalactosidasesIBA 04/2012
1	NucleotidesIBA 04/2012
1	Glycoproteins (Glycoprotein)IBA 02/2012
1	globotriaosyl lysosphingolipidIBA 09/2010
1	GlycolipidsIBA 09/2010
1	Iduronidase (alpha-L-Iduronidase)IBA 09/2008
1	SugarsIBA 03/2007
1	G(M2) Ganglioside (Ganglioside GM2)IBA 03/2007
1	mannose-6-phosphateIBA 01/2006
1	agalsidase beta FDA Link 01/2006
1	Bovine Serum AlbuminIBA 01/2006
1	Collagen Type IV (Type IV Collagen)IBA 02/2005
1	Peptides (Polypeptides)IBA 02/2005
1	CollagenIBA 02/2005
1	beta-MannosidaseIBA 11/2004
1	Tn antigenIBA 01/2004
1	Amino Acids FDA Link 10/2002
1	GlycosidesIBA 10/2002

Therapy/Procedure

5	Enzyme Replacement Therapy 02/2012 - 01/2006
1	Drug Therapy (Chemotherapy) 10/2012
1	Investigational Therapies (Experimental Therapy) 10/2012
1	Lasers (Laser) 10/2002